258 related articles for article (PubMed ID: 32449969)
1. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
[TBL] [Abstract][Full Text] [Related]
2. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
[TBL] [Abstract][Full Text] [Related]
3. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
[TBL] [Abstract][Full Text] [Related]
4. Testing for hepatitis C virus infection in UK prisons: What actually happens?
Jack K; Thomson BJ; Irving WL
J Viral Hepat; 2019 Jun; 26(6):644-654. PubMed ID: 30702194
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
Perrett SE; Plimmer A; Shankar AG; Craine N
J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
[TBL] [Abstract][Full Text] [Related]
7. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
[TBL] [Abstract][Full Text] [Related]
8. Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.
Martin NK; Vickerman P; Brew IF; Williamson J; Miners A; Irving WL; Saksena S; Hutchinson SJ; Mandal S; O'Moore E; Hickman M
Hepatology; 2016 Jun; 63(6):1796-808. PubMed ID: 26864802
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
Eisen L; Mor Z; Madar M; Rabinovitch R; Dadon Y; Sheffer R; Kaliner E; Goldstein L
Emerg Infect Dis; 2023 Nov; 29(11):2358-2361. PubMed ID: 37877627
[TBL] [Abstract][Full Text] [Related]
10. A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J
J Hepatol; 2023 Sep; 79(3):635-644. PubMed ID: 37116714
[TBL] [Abstract][Full Text] [Related]
11. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
[TBL] [Abstract][Full Text] [Related]
12. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
[TBL] [Abstract][Full Text] [Related]
13. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
[TBL] [Abstract][Full Text] [Related]
14. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
[TBL] [Abstract][Full Text] [Related]
15. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
[TBL] [Abstract][Full Text] [Related]
16. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
[TBL] [Abstract][Full Text] [Related]
17. Consensus recommendations on the management of hepatitis C in Australia's prisons.
Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
Bundle N; Balasegaram S; Parry S; Ullah S; Harris RJ; Ahmad K; Foster GR; Tong CY; Orkin C
Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290390
[TBL] [Abstract][Full Text] [Related]
19. How do people in prison feel about opt-out hepatitis C virus testing?
Jack K; Linsley P; Thomson BJ; Irving WL
J Viral Hepat; 2020 Oct; 27(10):1003-1011. PubMed ID: 32488916
[TBL] [Abstract][Full Text] [Related]
20. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
